Document is current
Any future updates will be listed below
-
Authors
Lindelöf, Hillevi
Hammarsjö, Anna
Voss, Ulrika
Gaetana Piticchio, Serena
Conner, Peter
Papadogiannakis, Nikos
Batkovskyte, Dominyka https://orcid.org/0000-0002-0492-1259
Orellana, Laura https://orcid.org/0000-0003-1927-555X
Kvarnung, Malin
Malmgren, Helena
Lagerstedt Robinson, Kristina
Nordgren, Ann https://orcid.org/0000-0003-3285-4281
Lindstrand, Anna https://orcid.org/0000-0003-0806-5602
Nishimura, Gen
Grigelioniene, Giedre https://orcid.org/0000-0001-9601-3137
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (VR 2021-02248)
Karolinska Institutet
Stiftelsen Promobilia
Stiftelsen Frimurare Barnhuset i Stockholm
Stockholms Läns Landsting
The Swedish rare diseases research foundation
Cancerfonden (CF 21 1471 Pj, CF 21 0305 JIA)
- License Information
-
More Information
Article History
Received: 9 December 2024
Revised: 16 April 2025
Accepted: 23 May 2025
First Online: 11 June 2025
Competing interests
: The authors declare no competing interests.
: Ethical approval was given by the Regional Ethical Review Authority in Stockholm (ethics protocol numbers 2014/983-31/1, 2012/2106-31/4 (addendum 2018/2207-32) and KS 2012/222-31-3 (addendum 2023-00178-02). Cases 1, 7,11,12,15,20,22-23,25,28-32 were included in the study with written informed consent as part of the combined clinical and research project (ethics protocol numbers 2014/983-31/1, 2012/2106-31/4 (addendum 2018/2207-32). Written informed consent was obtained for the publication of radiographs, clinical and molecular data. The research followed the principles of the Helsinki Declaration.
